News
Modular Medical Announces Pricing of $15 Million Public Offering and Uplisting to the Nasdaq Capital Market
SAN DIEGO, CA / February 10, 2022 / Modular Medical, Inc., (NASDAQ:MODD) (the "Company" or "Modular Medical"), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes...
Steven G. Felsher and Philip B. Sheibley Appointed to Board of Directors of Modular Medical, Inc.
SAN DIEGO, CA / November 29, 2021 / Modular Medical, Inc. (the "Company" or "Modular Medical") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes...
Modular Medical, Inc. Announces Reverse Stock Split in Connection with Application for Uplisting on the NASDAQ Capital Market
SAN DIEGO, CA / November 26, 2021 / Modular Medical, Inc. (the "Company") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians...
Modular Medical Expands Executive Team with Appointment Of Lynn O’Connor Vos as New CEO
O'Connor Vos Brings Deep Experience in Market Development, Commercializing Products and Patient AdvocacySAN DIEGO, CA / August 16, 2021 / Modular Medical, Inc. (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without...
Modular Medical Welcomes Global Healthcare Leader Lynn Vos to its Board of Directors
SAN DIEGO, CA / May 25, 2021 / Modular Medical, Inc. (OTCQB:MODD), a medical device company focused on next generation insulin delivery technologies to widen the accessibility of insulin pumps to a greater share of people with type 1 and type 2 diabetes, is pleased to...
Modular Medical Announces Financing
SAN DIEGO, CA / May 12, 2021 / Modular Medical, Inc. (OTCQB:MODD), a medical device company focused on next generation insulin delivery technologies to widen the accessibility of insulin pumps to a greater share of people with type 1 and type 2 diabetes, announced...
Modular Medical Establishes a Distinguished Multi-Disciplinary Advisory Board
A group of prominent health care professionals and experts in the use and development of diabetes technology brings extensive insights across the spectrum of patient care SAN DIEGO, CA / March 18, 2021 / Modular Medical, Inc. (OTCQB: MODD), a development-stage company...
Modular Medical Relocates to Larger Corporate Headquarters
The 7,300 square foot facility features a clean-room manufacturing environment and environmentally controlled test labs SAN DIEGO, CA / March 16, 2021 / Modular Medical, Inc. (OTCQB:MODD), a development-stage company focused on the next generation of easy to use,...
Modular Medical Uplists to OTCQB Venture Market
SAN DIEGO, CA / February 18, 2021 / Modular Medical, Inc. (OTCQB:MODD), a development-stage company in the diabetes/insulin delivery space, today announced its successful uplisting to the OTCQB® Venture Market. Modular Medical's common stock will continue to trade...